Read More

Telesis Bio Inc. Announces Strategic Focus On Game-Changing Gibson Sola Enzymatic DNA Synthesis Platform And BioXp mRNA Solutions; Todd R. Nelson To Step Down As CEO, Eric Esser, President And COO Of Telesis Bio, Will Assume The Role Of The Co’s CEP,…

Telesis Bio Inc. (NASDAQ:TBIO), a leader in automated benchtop DNA and mRNA synthesis solutions, today announced a focus in strategy enabled by the commercial availability of its groundbreaking Gibson SOLA platform.

TBIO